RYTHM 3Q 2026: Revenue $23.9M, Net loss $533K, EPS ($0.07) — 10-Q Summary

RYTHM, Inc. reported Q3 2026 revenue of $23.9M, up 490% YoY, driven by licensing. Net loss narrowed to $533K from $10.7M YoY, with EPS at ($0.07). Nine-month revenue rose 808% to $60.2M. The company warned of potential sales declines due to upcoming federal restrictions.

Original reporting
Published Nov 4, 2026, 12:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 12:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RYTHM 3Q 2026: Revenue $23.9M, Net loss $533K, EPS ($0.07) — 10-Q Summary — source image
Decision brief

The 30-second read

$RYMBullishMed
01

Why it matters

The earnings beat and loss narrowing provide fresh material for traders, though sector risk remains high.

02

Market read

New earnings data could drive short‑term price movement; sector risk from pending regulations.

03

What to watch

Potential supply‑chain constraints and state‑level regulatory variance may affect future revenue.

Relevance 6/10Novelty 7/10Timing: after‑hours release

Background

RYTHM, Inc. is a micro‑cap cannabis company reporting its Q3 2026 results via a 10‑Q filing.

Company-level read

Ticker impact

$RYMBullishHigh confidence
Context

RYTHM, Inc. disclosed Q3 2026 revenue of $23.9M and a narrowed net loss of $533K in its 10‑Q filing.

Expected impact

potential upside as the market prices in the improved earnings profile

Evidence & confidence

The sharp revenue growth and loss reduction are fresh, material data for a micro‑cap, suggesting price appreciation.

Market effects

Highlights rapid growth in the hemp‑THC licensing segment, may boost peer valuations.

U.S. hemp‑THC market faces upcoming federal restrictions, adding regulatory risk.

Limited to niche cannabis sector; minimal broader market effect.

Counterpoint

Upcoming federal restrictions could sharply curtail sales, offsetting growth momentum.

Key entities

  • RYTHM, Inc.

    Cannabis firm reporting Q3 2026 results.

Related articles

$RYMMed

RYTHM, Inc. Reports Third Quarter 2026 Results

RYTHM, Inc. (RYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 RYTHM, Inc. Reports Third Quarter 2026 Results ROLLING MEADOWS, IL, November 4, 2026 – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company, whose portfolio of trusted THC brands includes RYTHM, Señorita, incredibles, Beboe, and Dogwalkers, tod

$GTBIFMed

Green Thumb Amends RYTHM Notes and Warrants, Removes Ownership Cap; $72M Notes Affected

Green Thumb Industries (GTBIF) amended its secured convertible notes, pre-funded warrants, and shared services agreement with RYTHM to remove a 49.99% beneficial ownership cap. The amendment affects $72.0M of original principal and warrants for up to 9,731,638 shares, effective Oct 10, 2026. Green Thumb will consolidate RYTHM from that date, without intending to exercise the securities.

$RYMMed

RYTHM, Inc. Reports Second Quarter 2026 Results

RYTHM, Inc. (RYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 RYTHM, Inc. Reports Second Quarter 2026 Results ROLLING MEADOWS, IL, August 4, 2026 (GLOBE NEWSWIRE) – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company whose portfolio of trusted THC brands includes RYTHM, Señorita, incredibles, Beboe, and

$RYMMedAI 8/10

Daily NZX update, Friday, June 5, 2026

NZX 50 was up 0.3% at 3:00pm, though down 0.5% over five days and 2.6% over six months. Top gainers included Air New Zealand (+2%), Mainfreight (+2%) and Genesis Energy (+2%); biggest fallers were Kathmandu (-3%), A2 Milk (-2%) and Tourism Holdings (-2%). SmartShares ETFs were mixed. Meridian welcomed a draft Fast-track Panel decision on Lake Pūkaki access; Infratil completed a $200m capital bond offer; Ryman reported FY26 EBITDAF $88.3m and free cash flow $188.3m.

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.